American Medical Seminars Infectious Disease and Malpractice 2026
+ Target Audience: Infectious disease specialists, internal medicine physicians, family physicians, primary care physicians, hospitalists, emergency medicine physicians, travel and tropical medicine specialists, pulmonologists, dermatologists, addiction medicine specialists, pain management physicians, gastroenterologists, hepatologists, preventive medicine physicians, clinical pharmacists, nurse practitioners, physician assistants, medical residents, and healthcare professionals involved in infection management, medication safety, and patient care.
+ Information:
- Course Title: Infectious Disease and Malpractice
- Organizer: American Medical Seminars, Inc. (AMS)
- Course Dates: July 13–16, 2026
- Duration: Four Days
- Daily Schedule: 7:30 AM – 12:50 PM
- Original Location: Sonesta Resort Hilton Head Island, South Carolina, USA
- Educational Format: Conference Lectures and Clinical Discussions
- Primary Specialty: Infectious Diseases
- Additional Focus: Internal Medicine, Primary Care, Medication Safety, and Medical Malpractice
- Language: English
+ Description:
The American Medical Seminars Infectious Disease and Malpractice 2026 is a four-day continuing medical education program designed to provide physicians and healthcare professionals with practical clinical updates in infectious diseases, internal medicine, primary care, medication safety, and medical malpractice risk management.
Organized by American Medical Seminars, Inc. (AMS), the curriculum covers adult immunizations, global and travel medicine, tick-borne illnesses, tuberculosis, non-tuberculous mycobacterial infections, skin and soft tissue infections, pneumonia, lymphadenopathy, fever of unknown origin, gastroenteritis, sexually transmitted infections, viral hepatitis, and HIV.
The course also examines important patient safety and medicolegal topics, including medical malpractice lawsuits, FDA boxed warnings, opioid and benzodiazepine risks, QT interval prolongation, medication-related adverse effects, and the evolving risk-benefit profile of fluoroquinolone antibiotics.
Through expert-led lectures and clinically focused discussions, the program emphasizes diagnostic accuracy, evidence-based treatment, infection prevention, medication safety, and strategies for reducing preventable clinical risks.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Review appropriate immunization recommendations for adults in different clinical and occupational risk groups.
- Recognize common infectious diseases encountered in primary care and hospital medicine.
- Apply practical diagnostic approaches to tuberculosis, atypical mycobacterial infections, and tick-borne illnesses.
- Develop appropriate assessment and management strategies for skin and soft tissue infections.
- Evaluate patients presenting with lymphadenopathy or fever of unknown origin.
- Review evidence-based approaches to the diagnosis and treatment of common gastrointestinal infections.
- Develop differential diagnoses and management strategies for common sexually transmitted infection syndromes.
- Recognize infectious and medical complications associated with illicit substance use.
- Apply appropriate preventive recommendations for patients traveling internationally.
- Review clinical considerations in viral hepatitis and HIV management.
- Recognize medication-related risks associated with opioids, benzodiazepines, and other commonly prescribed drugs.
- Understand the clinical significance of FDA boxed warnings.
- Identify medication-related QT interval risks and relevant prescribing considerations.
- Evaluate important safety concerns associated with fluoroquinolone antibiotics.
- Identify clinical practices that may reduce medical malpractice exposure and improve patient safety.
Comprehensive Course Topics
1. Adult Immunization and Preventive Infectious Disease Care
Adult immunization recommendations, vaccination for healthcare workers, immunization in high-risk populations, long-term care vaccination, infection prevention, and risk-based vaccination strategies.
2. Travel and Global Medicine
Global medicine experiences, international travel health advice, travel-related infection prevention, clinical risk assessment, infectious disease considerations for travelers, and preventive counseling.
3. Tick-Borne Diseases
Recognition of tick-borne infections, clinical presentation, diagnostic evaluation, differential diagnosis, treatment considerations, and patient education.
4. Tuberculosis and Mycobacterial Infections
Tuberculosis, non-tuberculous mycobacterial infections, diagnostic testing, clinical interpretation, treatment approaches, and infection control considerations.
5. Skin and Soft Tissue Infections
Bacterial skin infections, soft tissue infections, clinical assessment, differential diagnosis, antimicrobial treatment considerations, and recognition of complicated infections.
6. Pneumonia and Respiratory Infections
Pneumonia evaluation, respiratory infection assessment, differential diagnosis, clinical decision-making, and treatment considerations.
7. Lymphadenopathy and Fever of Unknown Origin
Evaluation of lymphadenopathy, differential diagnosis, fever of unknown origin, diagnostic testing, clinical investigation, and referral considerations.
8. Gastrointestinal Infections
Gastroenteritis, infectious diarrhea, clinical assessment, diagnostic approaches, treatment considerations, and gastroenterology guideline applications.
9. Sexually Transmitted Infections
Urethritis, genital ulcers, vaginitis, diagnostic evaluation, treatment considerations, prevention, and patient counseling.
10. Viral Hepatitis and HIV
Viral hepatitis, hepatitis classification, HIV infection, primary care considerations, diagnostic evaluation, and clinical management principles.
11. Substance Use and Infectious Complications
Illicit drug use, opioid-related health risks, infectious complications, clinical assessment, overdose-related considerations, and patient safety.
12. Medical Malpractice and Clinical Risk Reduction
Medical malpractice lawsuits, adverse clinical outcomes, clinical documentation, medication-related risks, patient safety, risk reduction strategies, and clinical decision-making.
13. FDA Boxed Warnings and Medication Safety
FDA boxed warnings, opioid-related safety risks, benzodiazepine prescribing considerations, commonly prescribed medications, QT interval prolongation, fluoroquinolone safety, risk-benefit assessment, and medication monitoring.
Detailed Conference Program
Day 1 — Monday, July 13, 2026
Focus: Adult Immunizations, Global Medicine, Tick-Borne Diseases, Mycobacterial Infections, and Skin Infections
| Time | Lecture | Faculty |
|---|---|---|
| 7:30–8:30 AM | Immunizations for Adults | Stephen Gluckman, MD |
| 8:35–9:35 AM | Global Medicine Experiences | Stephen Gluckman, MD |
| 9:40–10:40 AM | Common Issues Surrounding Tick-Borne Illnesses in the U.S. | Stephen Gluckman, MD |
| 10:45–11:45 AM | TB and Non-TB Mycobacterial Infection Update 2025 | John Crane, MD |
| 11:50 AM–12:50 PM | Skin & Soft Tissue Infections | John Crane, MD |
Day 2 — Tuesday, July 14, 2026
Focus: Substance Use, Pneumonia, Lymphadenopathy, Travel Medicine, and Fever of Unknown Origin
| Time | Lecture | Faculty |
|---|---|---|
| 7:30–8:30 AM | Health Complications of Illicit Drug Use | John Crane, MD |
| 8:35–9:35 AM | Pneumonias We Have Known | John Crane, MD |
| 9:40–10:40 AM | Evaluating Lymphadenopathy | Stephen Gluckman, MD |
| 10:45–11:45 AM | Health Advice for International Travel | Stephen Gluckman, MD |
| 11:50 AM–12:50 PM | Fever of Unknown Origin | Stephen Gluckman, MD |
Day 3 — Wednesday, July 15, 2026
Focus: Gastrointestinal Infections, Sexually Transmitted Diseases, Medical Malpractice, and Medication Safety
| Time | Lecture | Faculty |
|---|---|---|
| 7:30–8:30 AM | Gastroenteritis | Stephen Gluckman, MD |
| 8:35–9:35 AM | Sexually Transmitted Diseases | Stephen Gluckman, MD |
| 9:40–10:40 AM | Good Medicine, Bad Outcomes, and Malpractice Lawsuits | Paul Axelsen, MD |
| 10:45–11:45 AM | When to Read Black Box Warnings, and When to Heed Them | Paul Axelsen, MD |
| 11:50 AM–12:50 PM | Black Box Warnings About Opioids and Benzodiazepines | Paul Axelsen, MD |
Day 4 — Thursday, July 16, 2026
Focus: Medication Risk, QT Interval, Fluoroquinolones, Viral Hepatitis, and HIV
| Time | Lecture | Faculty |
|---|---|---|
| 7:30–8:30 AM | Black Box Warnings About Commonly Used Drugs | Paul Axelsen, MD |
| 8:35–9:35 AM | Common Drugs and the QT Interval | Paul Axelsen, MD |
| 9:40–10:40 AM | The Changing Risk/Benefit Profile of Fluoroquinolone Antibiotics | Paul Axelsen, MD |
| 10:45–11:45 AM | The Alphabet Soup of Viral Hepatitis | Stephen Gluckman, MD |
| 11:50 AM–12:50 PM | What Every Primary Care Provider Should Know About HIV | Stephen Gluckman, MD |
Program Summary: Four conference days featuring 20 scheduled educational lectures. The original course description refers to continuous daily video recordings, which does not necessarily mean that each lecture is supplied as a separate video file.
Presenting Faculty
Stephen Gluckman, MD
Emeritus Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Medical Director, Penn Global Medicine, Philadelphia, Pennsylvania.
His sessions cover adult immunization, global and travel medicine, tick-borne diseases, lymphadenopathy, fever of unknown origin, gastrointestinal infections, sexually transmitted infections, viral hepatitis, and HIV.
John Crane, MD
Professor of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo; Chief of Infectious Diseases Section and Hospital Epidemiologist, Erie County Medical Center; Co-Medical Director, Erie County TB Clinic, Buffalo, New York.
His lectures address mycobacterial infections, skin and soft tissue infections, complications of illicit drug use, and pneumonia.
Paul Axelsen, MD
Faculty member associated with the Departments of Pharmacology, Biochemistry and Biophysics, and Medicine, Infectious Diseases Section, University of Pennsylvania School of Medicine.
His lectures focus on medical malpractice, medication safety, FDA boxed warnings, opioid and benzodiazepine risks, QT interval considerations, and fluoroquinolone prescribing concerns.
Educational Highlights
- Four-day infectious disease and medication safety review
- 20 scheduled clinical lectures
- Adult vaccination and preventive care
- Global and travel medicine
- Tick-borne and mycobacterial infections
- Skin and soft tissue infections
- Respiratory and gastrointestinal infections
- Lymphadenopathy and fever of unknown origin
- Sexually transmitted diseases
- Viral hepatitis and HIV
- Health complications of illicit drug use
- Medical malpractice and clinical risk management
- FDA boxed warnings
- Opioid and benzodiazepine safety
- QT interval considerations
- Fluoroquinolone risk-benefit assessment
- Practical primary care and internal medicine applications
Clinical & Educational Value
The American Medical Seminars Infectious Disease and Malpractice 2026 provides a multidisciplinary medical education review relevant to infectious disease specialists, internists, family physicians, hospitalists, and other healthcare professionals.
The course integrates infectious disease diagnosis and treatment with medication safety, clinical risk assessment, medical malpractice awareness, and evidence-informed approaches to patient care.
Its curriculum supports clinical reasoning, appropriate treatment selection, improved recognition of medication-related risks, and greater awareness of factors contributing to preventable adverse outcomes.
Important Access Information
This description summarizes the original AMS educational conference. The number, format, and completeness of digital files included in the purchased package should be confirmed before purchase.
Official conference registration, live participation, provider platform access, CME credits, and certificates are not included unless expressly stated.
Short Description
The American Medical Seminars Infectious Disease and Malpractice 2026 provides clinical updates in adult immunizations, travel medicine, tuberculosis, tick-borne infections, skin and soft tissue infections, pneumonia, gastrointestinal infections, sexually transmitted diseases, viral hepatitis, HIV, FDA boxed warnings, medication safety, and medical malpractice risk management.




